Enflicoxib for the long-term management of canine osteoarthritis—External validation of a population pharmacokinetic model in dogs with osteoarthritis
The established popPK model in healthy Beagle dogs can predict the PK behavior of enflicoxib and its pyrazol metabolite in dogs of any breed with OA. The lack of time-dependent PK provides a PK rationale to support continuous enflicoxib treatment for as long as therapeutically required.
Authors
- Josep Homedes (ORCID: https://orcid.org/0000-0001-5440-7699)
- José Miguel Vela (ORCID: https://orcid.org/0000-0002-6809-1477)
- Gregorio Encina (ORCID: https://orcid.org/0000-0001-5953-8911)
- Marta Salichs (ORCID: https://orcid.org/0000-0003-2456-0726)
- J. M. Cendros
Institutions
- Veterinarians Without Borders (US)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Frontiers in Veterinary Science
- Published
- 2025-09-24
- DOI
- https://doi.org/10.3389/fvets.2025.1645857
- Primary Topic
- Veterinary Orthopedics and Neurology
- Type
- article
- Field-Weighted Citation Impact
- 0.00